Completed Genetics & Molecular Biology Pregnancy, Children & Inherited Conditions

Deciphering the Mechanisms of Developmental Disorders (DMDD).

In plain English

AI plain-English summary

Scientists are systematically creating thousands of mouse embryos with single genes disabled, then scanning them with high-resolution CT and 3D imaging to catalogue every structural defect that appears. This matters because thousands of children are born each year with developmental disorders of unknown genetic cause. While human genome sequencing can identify suspicious mutations, proving that a particular gene actually causes a birth defect requires experimental evidence. The Sanger Institute’s Mouse Genetics Project is generating knockout mice for every gene in the mouse genome, and this project—Deciphering the Mechanisms of Developmental Disorders (DMDD)—will focus on the 250-plus genes that prove essential for normal development. By combining detailed anatomical imaging with gene expression analysis at precise developmental stages, the team will map the regulatory networks that go wrong when a gene is missing. The project’s primary output is a single public database, linked to the International Mouse Phenotyping Consortium, where clinicians and developmental biologists can look up what happens when a specific mouse gene is disabled. If a child carries a mutation in the human version of that gene, the database provides immediate evidence of what that mutation likely does. This is fundamental science with a direct pipeline to clinical diagnosis—it turns a list of candidate disease genes into a catalogue of real biological consequences.

View original technical description
The proposal aims to capitalize on the unique resource of knockout mouse strains being generated by the Sanger Institute Mouse Genetics Project pipeline. Over the next 5 years the MGP primary screen will identify in excess of 250 genes essential for normal development. The DMDD project will employ high throughput imaging ( CT and HREM) of mutant embryos to identify and catalog structural developmental defects. Possible contributions resulting from disturbed placental development will be assess ed. Phenotypic characterization in conjunction with high-throughput transcriptomic analysis at defined developmental stages will provide new information about gene regulatory networks underpinning normal development. The efforts of the DMDD project will be guided by interactions with Deciphering Developmental Disorders and the MRC Developmental Anomalies Consortia, to prioritize generation and analysis of mutants in mouse genes orthologous to disease alleles identified by human genetic studies. The major output of DMDD will be a single, publicly-available database, fully linked into the International Mouse Phenotyping Consortium and designed to facilitate access by the clinical and developmental biology community. Our goals are dissemination of primary phenotyping information, encouraging maximal uptake of mutant strains by laboratories for future in-depth analysis and advancing identification of developmental disease alleles.

View the original record at the funder ↗

Researchers

James Smith (EPMC Awardee)Mike Stratton (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

National Mouse Genetics Netwrok (NMGN) Data Platform Development
Engineering of complex alleles
Discovering new disease pathways affecting mtdna metabolism
New embryological perspectives on imprinting disease
A long term resource to maximise the potential of laboratory mouse strains for medical research

Original classification

Strategic Award - Science

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.